Evidence map›Paper›PMID 25524126›Full record

ArticleBMC public health2014

First report on prevalence and risk factors of severe atypical pneumonia in Vietnamese children aged 1-15 years.

Phan Le Thanh Huong, Pham Thu Hien, Nguyen Thi Phong Lan, Tran Quang Binh, Dao Minh Tuan, Dang Duc Anh

Open access · goldAbstract read
In one paragraph

Article in BMC public health, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed, 1 pooled it
2.4field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 1 synthesis or guideline pooled it, 44 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. High prevalence and associated factors ofJournal of preventive medicine and hygiene · 2025
    Article
  4. Atypical pneumonia (Review).Experimental and therapeutic medicine · 2024
    Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Urinary antigene and PCR can both be used to detectEuropean journal of translational myology · 2019
    Article
  12. Detection ofInfection and drug resistance · 2019
    Article
  13. Review
  14. Article
  15. Review
  16. Serological Analysis and Drug Resistance ofBioMed research international · 2017
    Article
  17. Article
  18. Child pneumonia - focus on the Western Pacific Region.Paediatric respiratory reviews · 2017
    Review
  19. Recent Developments in Pediatric Community-Acquired Pneumonia.Current infectious disease reports · 2016
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Phan Le Thanh HuongNational Institute of Hygiene and Epidemiology, 1 Yersin street, Hanoi 10,000, Vietnam. thanhhuong@nihe.org.vn.
Pham Thu Hien
Nguyen Thi Phong Lan
Tran Quang Binh
Dao Minh Tuan
Dang Duc Anh
National Institute Of Hygiene And Epidemiology · VNNational Hospital of Pediatrics · VN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundAtypical pathogens such as Mycoplasma pneumoniae, Chlamydophila pneumoniae, and Legionella pneumophila are increasingly recognized as important causes of community acquired pneumonia (CAP) worldwide. Such etiological data for Vietnam is scarce and clinical doctors lack accurate information on which to base their diagnosis and treatment of pneumonia. This study identifies the prevalence and risk factors of severe community acquired pneumonia due to these atypical pathogens (severe-ApCAP) in children aged 1-15 years with CAP in a pediatric hospital in Hanoi, Vietnam.

methods722 hospitalized children with CAP were recruited for detecting those atypical pathogens, using multiplex PCR and ELISA. Clinical and epidemiological data were collected. Multivariate logistic-regression analyses were performed to evaluate the associations of potential risk factors with severe-ApCAP.

resultsAmong 215 atypical pathogen-positive CAP cases, 45.12% (97/215) were severe-ApCAP. Among the severe-ApCAP group, 55.67% (54/97) cases were caused by pure atypical pathogens and 44.33% (43/97) resulted from a co-infection with typical respiratory pathogens. M. pneumoniae was the most common, with 86.6% cases (84/97) in the severe-ApCAP group, whereas C. pneumoniae and L. pneumophila were less frequent (6.19% and 7.22%, respectively). The highest rate of severe-ApCAP was in children younger than two years (65.98%). The differences related to age are statistically significant (P = 0.008).The factors significantly associated with severe-ApCAP were age (OR = 0.84, 95% CI = 0.75-0.93, P = 0.001), co-infection with typical bacteria (OR = 4.86, 95% CI = 2.17-10.9, P < 0.0001), co-infection with respiratory viruses (OR = 4.36, 95% CI = 1.46-13.0, P = 0.008), respiratory/cardiac system malformation (OR = 14.8, 95% CI = 1.12-196, P = 0.041) and neonatal pneumonia (OR = 11.1, 95% CI = 1.06-116, P = 0.044).

conclusionsSevere-ApCAP presented at a significant rate in Vietnamese children. More than 50% of severe-ApCAP cases were associated with pure atypical pathogen infection. M. pneumoniae appeared most frequently. The highest rate of severe-ApCAP was in children younger than two years. Younger age and co-infection with typical bacteria or viruses were the most significant risk factors, while respiratory/cardiac system malformation and neonatal pneumonia were additional potential risk factors, associated with severe-ApCAP in Vietnamese children.

Indexed as

Chlamydophila pneumoniaeLegionella pneumophilaMycoplasma pneumoniaeAdolescentAge FactorsChildChild, PreschoolChlamydophila InfectionsCoinfectionCommunity-Acquired InfectionsFemaleHumansInfantLegionnaires' DiseaseMaleOdds Ratio

Identifiers

PMID25524126
PMCPMC4300840
OpenAlexW1480350482

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.